Delivery Order SPE2DB20D3103-SPE2DB25FP6L1
- Not listed
- The Defense Logistics Agency awarded a $157,016.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine product, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order was awarded on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $262,572.45 delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products. The contract, with a completion date of July 23, 2025, represents a competitive, non-set-aside award utilizing firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $45,143 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135) in 0.5ML format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,318.60 to AmerisourceBergen Drug Corp for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135-DIP) in 0.5mL dosage. This non-competitive delivery order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a time-sensitive pharmaceutical procurement fulfilled from the vendor's location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $42,163.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 vial (A-C-Y-W-135-diphtheria) 0.5 mL vaccines with an ultimate completion date of July 30, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a $79,278.21 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed-price contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside delivery order issued under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical. The place of performance is the company's corporate...
- The Defense Logistics Agency awarded a $169,665.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a $11,671.29 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5mL, a meningococcal conjugate vaccine. This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by August 12, 2025. Performance will occur at the contractor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- The Defense Logistics Agency (DLA) awarded a $61,593.00 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP (0.5ML), a meningococcal vaccine product. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL vaccine, with a ceiling value of $6,449.00. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6L1Delivery Order
The Defense Logistics Agency awarded a $152,714.53 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the company's comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor specializing in pharmaceutical products and medical supplies for military and veteran healthcare systems. The company's DLA IDC enables it to supply a diverse range of commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Menveo vaccine delivery order reflects the company's ongoing role as a key supplier within the Defense Logistics Agency's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $152.7k | 7/25/25 |